20,549 Shares in Quanterix Co. (NASDAQ:QTRX) Bought by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. acquired a new stake in shares of Quanterix Co. (NASDAQ:QTRXFree Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 20,549 shares of the company’s stock, valued at approximately $558,000. Jupiter Asset Management Ltd. owned 0.05% of Quanterix at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in QTRX. Deutsche Bank AG lifted its holdings in Quanterix by 6,788.3% in the 4th quarter. Deutsche Bank AG now owns 1,025,595 shares of the company’s stock valued at $14,204,000 after acquiring an additional 1,010,706 shares during the last quarter. Point72 Asset Management L.P. lifted its stake in Quanterix by 206.0% during the fourth quarter. Point72 Asset Management L.P. now owns 1,090,826 shares of the company’s stock valued at $15,108,000 after purchasing an additional 734,306 shares during the last quarter. Portolan Capital Management LLC boosted its holdings in Quanterix by 84.0% during the second quarter. Portolan Capital Management LLC now owns 1,416,623 shares of the company’s stock worth $31,945,000 after buying an additional 646,884 shares in the last quarter. Invesco Ltd. grew its position in Quanterix by 73.3% in the first quarter. Invesco Ltd. now owns 1,097,126 shares of the company’s stock worth $32,026,000 after buying an additional 464,139 shares during the last quarter. Finally, Emerald Advisers LLC acquired a new position in Quanterix in the third quarter worth approximately $10,462,000. Institutional investors own 86.64% of the company’s stock.

Analysts Set New Price Targets

Separately, Scotiabank initiated coverage on Quanterix in a research note on Thursday, February 1st. They set a “sector outperform” rating and a $30.00 price objective for the company. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $31.60.

View Our Latest Stock Analysis on QTRX

Quanterix Stock Performance

Shares of NASDAQ:QTRX opened at $24.28 on Monday. Quanterix Co. has a 52 week low of $10.02 and a 52 week high of $28.78. The firm has a 50 day simple moving average of $24.70 and a 200 day simple moving average of $24.23.

Quanterix Company Profile

(Free Report)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.

See Also

Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRXFree Report).

Institutional Ownership by Quarter for Quanterix (NASDAQ:QTRX)

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.